Salvage therapeutic strategies for bacillus Calmette–Guerin failure

@article{Hassler2019SalvageTS,
  title={Salvage therapeutic strategies for bacillus Calmette–Guerin failure},
  author={M. Hassler and S. Shariat and F. Soria},
  journal={Current Opinion in Urology},
  year={2019},
  volume={29},
  pages={239–246}
}
  • M. Hassler, S. Shariat, F. Soria
  • Published 2019
  • Medicine
  • Current Opinion in Urology
  • Purpose of review To give an overview of current options for conservative treatment of patients failing intravesical bacillus Calmette–Guerin (BCG) and to discuss emerging approaches with potential future clinical applications. Recent findings Radical cystectomy is the standard-of-care for patients failing BCG therapy. In patients unfit or unwilling to undergo surgery, salvage therapy options could be proposed with the aim to offer local cancer control and prevent progression to muscle-invasive… CONTINUE READING
    6 Citations

    References

    SHOWING 1-10 OF 59 REFERENCES
    Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.
    • G. Dalbagni, P. Russo, +6 authors D. Bajorin
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2006
    • 90